Renal Cell Carcinoma

Renal cell carcinoma (RCC, also known as hypernephroma) is a kidney cancer that originates in the lining of the proximal convoluted tubule, the very small tubes in the kidney that filter the blood and remove waste products.
What is Renal Cell Carcinoma?

Renal cell carcinoma, also called hypernephroma, is a cancer of the kidneys that forms in the proximal convoluted tubule. In the UK, it is the eighth most common cancer among adults, affecting 9,300 people every year.

Read More

Overview

Feature Articles

Latest Renal Cell Carcinoma News and Research

Using natural killers from the immune system to target breast cancer cells

Using natural killers from the immune system to target breast cancer cells

New study could help guide oncologists in selecting the best treatment for kidney cancers

New study could help guide oncologists in selecting the best treatment for kidney cancers

Advanced-stage kidney cancer more common in Hispanic and Native Americans in Arizona

Advanced-stage kidney cancer more common in Hispanic and Native Americans in Arizona

FDA issues noncompliance notice for failing to submit clinical trial summary results to ClinicalTrials.gov

FDA issues noncompliance notice for failing to submit clinical trial summary results to ClinicalTrials.gov

Baseline brain imaging should be considered in most metastatic kidney cancer patients, study suggests

Baseline brain imaging should be considered in most metastatic kidney cancer patients, study suggests

Cancer patients treated with immunotherapy at high risk of developing thrombotic complications

Cancer patients treated with immunotherapy at high risk of developing thrombotic complications

Researchers reveal a mechanistic link in kidney cancer between fat metabolism and obesity

Researchers reveal a mechanistic link in kidney cancer between fat metabolism and obesity

Studies reveal how kidney tumors' microenvironments change in response to immunotherapy

Studies reveal how kidney tumors' microenvironments change in response to immunotherapy

Targeted drug combined with immunotherapy prolongs survival in patients with advanced kidney cancer

Targeted drug combined with immunotherapy prolongs survival in patients with advanced kidney cancer

Study explores impact of surgical delay for renal cell carcinoma during COVID-19 pandemic

Study explores impact of surgical delay for renal cell carcinoma during COVID-19 pandemic

Genetic changes in tumors can help predict the efficacy of immunotherapy drugs

Genetic changes in tumors can help predict the efficacy of immunotherapy drugs

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Potentially promising therapeutic combination for renal cell carcinoma uncovered

Potentially promising therapeutic combination for renal cell carcinoma uncovered

Study reveals the role of SETD2 protein in cancer cells, cell migration, and autophagy

Study reveals the role of SETD2 protein in cancer cells, cell migration, and autophagy

Study demonstrates safety of novel immuno-oncology therapy in patients with advanced solid tumors

Study demonstrates safety of novel immuno-oncology therapy in patients with advanced solid tumors

Immunotherapy side effect could signal improved control of kidney cancer

Immunotherapy side effect could signal improved control of kidney cancer

UC study shows how tobacco use impacts patients with kidney cancer

UC study shows how tobacco use impacts patients with kidney cancer

Trial shows new first-line treatment option for patients with metastatic kidney cancer

Trial shows new first-line treatment option for patients with metastatic kidney cancer

New research reverses the understanding of kidney tumor growth

New research reverses the understanding of kidney tumor growth

New combination therapy helps fight cancer

New combination therapy helps fight cancer